TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34231532

Group type: EXPERIMENTAL
Intervention: Laser treatment for severe ROP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment (bevacizumab) for severe ROP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment (bevacizumab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment
Number of subjects: 0
Study: 32312727

Group type: EXPERIMENTAL
Intervention: Hydrosurgical debridement ± decellularised dermal allograft, or combination with negative pressure wound therapy, as an adjunct to treatment as usual (TAU)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: One treatment strategy continued from phase II
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Secondary objectives include healing status of the index ulcer, infection rate, reulceration, quality of life, cost-effectiveness, and incidence of adverse events
Number of subjects: 447
Study: 36191310

Group type: EXPERIMENTAL
Intervention: Upadacitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo or standard treatment not specified)
Number of subjects: 0
Study: 34488853

Group type: EXPERIMENTAL
Intervention: Culturally adapted Cognitive Behavioural Therapy (CaCBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Cognitive Behavioural Therapy (CBT)
Number of subjects: 0
Study: 32460790

Group type: EXPERIMENTAL
Intervention: 600 mg GBS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (microcrystalline cellulose)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 300 mg GBS
Number of subjects: 18
Study: 36262074

Group type: EXPERIMENTAL
Intervention: Rota-Cut
Number of subjects: 110

Group type: COMPARATOR
Intervention: Modified Balloon (MB)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Rotational Atherectomy (RA)
Number of subjects: 110
Study: 33966113

Group type: EXPERIMENTAL
Intervention: Mesotherapy (intra‐mucosal injection of ascorbic acid, 1/week for 3 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical gel (topical ascorbic acid gel, 1/day for 3 months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 35288066

Group type: EXPERIMENTAL
Intervention: Nivolumab (240 mg) every 2 weeks for ≤1 year
Number of subjects: 709

Group type: COMPARATOR
Intervention: Placebo every 2 weeks for ≤1 year
Number of subjects: 709
Study: 32576090

Group type: EXPERIMENTAL
Intervention: TASK-CBT (n=14)
Number of subjects: 27

Group type: COMPARATOR
Intervention: TASK-Relax (n=13)
Number of subjects: 27
Study: 37910474

Group type: EXPERIMENTAL
Intervention: Biophilic virtual classroom environments
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control virtual classroom environments (non-biophilic)
Number of subjects: 30
Study: 33205670

Group type: EXPERIMENTAL
Intervention: Comprehensive hypertension management approach
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional wellness practices
Number of subjects: 60
Study: 35660387

Group type: EXPERIMENTAL
Intervention: Original Gymnastics for Pregnant Women program
Number of subjects: 131

Group type: COMPARATOR
Intervention: Conventional intervention (Control)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Original Gymnastics for Pregnant Women program (with lower exercise frequency)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Original Gymnastics for Pregnant Women program (with reasonable exercise frequency)
Number of subjects: 131
Study: 34425471

Group type: EXPERIMENTAL
Intervention: Hua Shi Bai Du Granule (Q-14) plus standard care
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 204
Study: 32076564

Group type: EXPERIMENTAL
Intervention: Learning and Coping programme (LC-programme)
Number of subjects: 825

Group type: COMPARATOR
Intervention: Standard CR-programme
Number of subjects: 825
Study: 34103386

Group type: EXPERIMENTAL
Intervention: Rucaparib 600 mg twice daily
Number of subjects: 151
Study: 33021871

Group type: EXPERIMENTAL
Intervention: Afatinib plus Cetuximab
Number of subjects: 168

Group type: COMPARATOR
Intervention: Afatinib alone
Number of subjects: 168
Study: 36065653

Group type: EXPERIMENTAL
Intervention: Discharge training and telephone counseling for two months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 70
Study: 34544599

Group type: EXPERIMENTAL
Intervention: Px563L (10 mcg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Px563L (50 mcg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Px563L (80 mcg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: RPA563 (mrPA only)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Px563L (all doses)
Number of subjects: 54
Study: 35696185

Group type: EXPERIMENTAL
Intervention: Semorinemab 1500 mg
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Semorinemab 4500 mg
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Semorinemab 8100 mg
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study: 34274173

Group type: EXPERIMENTAL
Intervention: Medial crural cut and overlay (MCC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Lateral crural cut and overlay (LCC)
Number of subjects: 54
Study: 36096842

Group type: EXPERIMENTAL
Intervention: Lactofem plus letrozole
Number of subjects: 40

Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 40
Study: 32589339

Group type: EXPERIMENTAL
Intervention: Technology-enhanced group-based fitness intervention (eight in-person group sessions with mobile app and FitBit followed by 4 weeks of app and FitBit only)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 49
Study: 35387621

Group type: EXPERIMENTAL
Intervention: Robot-assisted group (RA, 37 patients)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Fluoroscopy-assisted group (FA, 44 patients)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Robot-assisted group (RA)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Fluoroscopy-assisted group (FA)
Number of subjects: 81
Study: 34401684

Group type: EXPERIMENTAL
Intervention: ADIE (Aligning Dimensions of Interoceptive Experience)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Exteroceptive control therapy (emotional prosody identification)
Number of subjects: 121
Study: 32957364

Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion self-administration + original antihypertensive drugs
Number of subjects: 600

Group type: COMPARATOR
Intervention: Original antihypertensive drugs without heat-sensitive moxibustion
Number of subjects: 600
Study: 33155035

Group type: EXPERIMENTAL
Intervention: Regularization method for Mendelian randomization analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard multivariable Mendelian randomization
Number of subjects: 0
Study: 34172065

Group type: EXPERIMENTAL
Intervention: Coalition Check-Up
Number of subjects: 68

Group type: COMPARATOR
Intervention: TA as usual
Number of subjects: 68
Study: 32912142

Group type: EXPERIMENTAL
Intervention: Abscisic acid
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Gibberellin
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Drought
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Salt
Number of subjects: 56
Study: 35583232

Group type: EXPERIMENTAL
Intervention: High-dose clazakizumab (25 mg)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 33529093

Group type: EXPERIMENTAL
Intervention: Inactivated monovalent EV-71 vaccine
Number of subjects: 7325

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7325
Study: 33093359

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 412

Group type: COMPARATOR
Intervention: Non-aspirin
Number of subjects: 412
Study: 35039189

Group type: EXPERIMENTAL
Intervention: modified constraint‐induced movement therapy (mCIMT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: bimanual training (BIT)
Number of subjects: 32
Study: 33999159

Group type: EXPERIMENTAL
Intervention: CJR hospitals
Number of subjects: 1087177

Group type: COMPARATOR
Intervention: Control hospitals
Number of subjects: 1087177
Study: 32538495

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg/kg
Number of subjects: 100
Study: 32703042

Group type: EXPERIMENTAL
Intervention: Intralesional MMR vaccine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intralesional Candida antigen
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intralesional saline
Number of subjects: 40
Study: 32352811

Group type: EXPERIMENTAL
Intervention: Mindfulness practice (daily diary assessments)
Number of subjects: 25
Study: 35419650

Group type: EXPERIMENTAL
Intervention: ELOM-080
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 34152785

Group type: EXPERIMENTAL
Intervention: Antigay condition
Number of subjects: 141

Group type: COMPARATOR
Intervention: Progay condition
Number of subjects: 141
Study: 32417819

Group type: EXPERIMENTAL
Intervention: Slow-tempo music
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Fast-tempo music
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Background music (both slow and fast tempo)
Number of subjects: 240

Group type: COMPARATOR
Intervention: No music
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 240
Study: 35533197

Group type: EXPERIMENTAL
Intervention: Glutamate infusion (0.125 M L-glutamic acid at 1.65 mL/kg/h)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control (saline infusion)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Glutamate infusion (in patients without diabetes)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control (in patients without diabetes)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Glutamate infusion
Number of subjects: 303
Study: 34229698

Group type: EXPERIMENTAL
Intervention: Predictive model for postoperative early-relapse
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 406
Study: 33993000

Group type: EXPERIMENTAL
Intervention: New type of 1D grating sample fabricated by combining laser‐focused atomic deposition and x‐ray interference lithography
Number of subjects: 0
Study: 33115436

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker (ARB) treatment with irbesartan (150–300 mg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both ARB and placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 81
Study: 35395638

Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mesenchymal stem cells (BM-MSCs)
Number of subjects: 27
Study: 33413459

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg) in the morning
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg) in the afternoon
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 15
Study: 36088445

Group type: EXPERIMENTAL
Intervention: PolyPrime intervention (online video and medication reviews scheduled twice)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PolyPrime intervention
Number of subjects: 120
Study: 32112507

Group type: EXPERIMENTAL
Intervention: dCBT
Number of subjects: 1711
Study: 35394159

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (alpha2-agonist)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Yohimbine (alpha2-antagonist)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 52
Study: 33844435

Group type: EXPERIMENTAL
Intervention: Home-visiting program (Primeiros Laços)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 80
Study: 36910402

Group type: EXPERIMENTAL
Intervention: Bilateral upper-extremity training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Upper limb exercise on the affected side only (Control)
Number of subjects: 0
Study: 33441116

Group type: EXPERIMENTAL
Intervention: Moderate resistance training (O55)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: High-load resistance training (O80)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Moderate resistance training (Y55)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (younger men, Y55)
Number of subjects: 38
Study: 34131846

Group type: EXPERIMENTAL
Intervention: Need-based program for family caregivers
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 64
Study: 32599668

Group type: EXPERIMENTAL
Intervention: Jennings Disaster Nursing Management Model‐based and learning management system‐assisted six‐module training programme
Number of subjects: 235
Study: 34665996

Group type: EXPERIMENTAL
Intervention: Minimalist Footwear Group (MFG)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional Footwear Group (CFG)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups (MFG and CFG)
Number of subjects: 42
Study: 33608590

Group type: EXPERIMENTAL
Intervention: Fulvestrant
Number of subjects: 171
Study: 33194565

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue adhesive (n = 23)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Subcuticular suture (n = 24)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue adhesive
Number of subjects: 50

Group type: COMPARATOR
Intervention: Subcuticular suture
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue adhesive and Subcuticular suture
Number of subjects: 50
Study: 36506418

Group type: EXPERIMENTAL
Intervention: Economic empowerment only (EE only)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Multiple family group-based family strengthening only (MFG-based FS only)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Combined economic empowerment and multiple family group-based family strengthening (EE + MFG-based FS)
Number of subjects: 900
Study: 32097435

Group type: EXPERIMENTAL
Intervention: ADVAX DNA prime followed by MVA boost
Number of subjects: 0

Group type: COMPARATOR
Intervention: MVA alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35410375

Group type: EXPERIMENTAL
Intervention: Epinephrine and Dexamethasone
Number of subjects: 410

Group type: COMPARATOR
Intervention: Placebo (Supportive Care)
Number of subjects: 410
Study: 34158030

Group type: EXPERIMENTAL
Intervention: Flipped learning integrated into SBME training on NTS
Number of subjects: 102

Group type: COMPARATOR
Intervention: Lecture-based learning (LBL) on NTS
Number of subjects: 102
Study: 32838783

Group type: EXPERIMENTAL
Intervention: Family-administered screening with a 6.9 cm card for assessing baby's foot size.
Number of subjects: 2022
Study: 34743455

Group type: EXPERIMENTAL
Intervention: Lesion removal + whole breast exploration and washing + micro-plastic surgery
Number of subjects: 97

Group type: COMPARATOR
Intervention: Empirical breast lesion resection + fascia tissue flap plasty + nipple and areola correction
Number of subjects: 97
Study: 33244575

Group type: EXPERIMENTAL
Intervention: Frailty related to diseases
Number of subjects: 195
Study: 35098601

Group type: EXPERIMENTAL
Intervention: Fitness app and activity tracker (treatment group)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (no fitness app or activity tracker)
Number of subjects: 216
Study: 34214661

Group type: EXPERIMENTAL
Intervention: Congested side unilateral nostril breathing (UNB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patent side unilateral nostril breathing (UNB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breathing through both nostrils
Number of subjects: 0
Study: 34209273

Group type: EXPERIMENTAL
Intervention: Alcoholic beer (AB) - 330 mL/day
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Non-alcoholic beer (NAB) - 660 mL/day
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study: 32233247

Group type: EXPERIMENTAL
Intervention: Hand power device and SJX external granule
Number of subjects: 50

Group type: COMPARATOR
Intervention: Loose training of metacarpophalangeal joints
Number of subjects: 50
Study: 34337827

Group type: EXPERIMENTAL
Intervention: Loss-framed message
Number of subjects: 2169

Group type: EXPERIMENTAL
Intervention: Loss-framed material
Number of subjects: 2169

Group type: COMPARATOR
Intervention: Gain-framed material
Number of subjects: 2169
Study: 32306694

Group type: EXPERIMENTAL
Intervention: 8-week Balint group intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 78
Study: 35199938

Group type: EXPERIMENTAL
Intervention: Enhanced audit and feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple imputation
Number of subjects: 0
Study: 34115953

Group type: EXPERIMENTAL
Intervention: L-DGG (Er,Cr:YSGG-harvested DGG and root surface biomodified)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: B-DGG/LRB (B-DGG and Er,Cr:YSGG root surface biomodification)
Number of subjects: 24

Group type: COMPARATOR
Intervention: B-DGG (blade-harvested DGG, control group)
Number of subjects: 24
Study: 35489789

Group type: EXPERIMENTAL
Intervention: Peripheral arterial disease screening of at-risk patients with oversampling of high-risk racial groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Introduction of an intervention to alter a social determinant of health
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of an algorithm that requires criteria be met prior to an amputation
Number of subjects: 0
Study: 32717273

Group type: EXPERIMENTAL
Intervention: High Velocity Resistance Exercise (HVRE)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Traditional Resistance Exercise (TRE)
Number of subjects: 14
Study: 34529773

Group type: EXPERIMENTAL
Intervention: Cognitive determinants (Trail Making Test A and B)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Physical determinants (gait speed, lower extremity power, 6-Minute Walk Test, Figure of 8 Walk Test, tandem stance, energy cost of walking, Late-Life Function and Disability Function Scale)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Psychosocial determinants (Modified Gait Efficacy Scale)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Financial determinants (neighborhood socioeconomic status)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Lower extremity power
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Gait efficacy
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Energy cost of walking
Number of subjects: 249
Study: 32285978

Group type: EXPERIMENTAL
Intervention: Flavor- and taste-themed advertisements
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: People- and product use-themed advertisements
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: General advertisements
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Prior advertisement exposure
Number of subjects: 1063

Group type: COMPARATOR
Intervention: Control advertisements for bottled water
Number of subjects: 1063
Study: 35848935

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) group intervention, 14 sessions of 2 hours each
Number of subjects: 171
Study: 34214668

Group type: EXPERIMENTAL
Intervention: Proteomic analysis of glaucoma aqueous humour
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Proteomic analysis of PAACG, PCACG, and NVG
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Proteomic analysis of NVG
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Proteomic analysis of PAACG
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: SERPIND1 role in glaucoma
Number of subjects: 175
Study: 32871336

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 35903434

Group type: EXPERIMENTAL
Intervention: Optical enhanced endoscopy
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (standard endoscopy)
Number of subjects: 188
Study: 33077119

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg ⋅ kg‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 35261292

Group type: EXPERIMENTAL
Intervention: Honey drops for postoperative care for 2 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Warm saline solution for postoperative care
Number of subjects: 50
Study: 33533652

Group type: EXPERIMENTAL
Intervention: Likert items with normal instructions
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Forced choice items with normal instructions
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Likert items with instructions to make a positive impression
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Forced choice items with instructions to make a positive impression
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Statements with normal instructions
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Adjectives with normal instructions
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Statements with instructions to make a positive impression
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: Adjectives with instructions to make a positive impression
Number of subjects: 1798

Group type: EXPERIMENTAL
Intervention: ACT scores
Number of subjects: 1798
Study: 32652684

Group type: EXPERIMENTAL
Intervention: Endoscopic radial artery harvest (ERAH)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open radial artery harvest (ORAH)
Number of subjects: 50
Study: 34433892

Group type: EXPERIMENTAL
Intervention: XGB model
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: DNN model
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: LGBM model
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: Machine learning models
Number of subjects: 2349
Study: 32376981

Group type: EXPERIMENTAL
Intervention: Telephone Disclosure (TD)
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Telephone Disclosure (TD) without medical follow-up
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Telephone Disclosure (TD) with medical follow-up
Number of subjects: 970

Group type: COMPARATOR
Intervention: In-Person Disclosure (IPD)
Number of subjects: 970